419 related items for PubMed ID: 31548437
1. Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017.
Xie LP, Yan WL, Huang M, Huang MR, Chen S, Huang GY, Liu F.
J Epidemiol; 2020 Oct 05; 30(10):429-435. PubMed ID: 31548437
[Abstract] [Full Text] [Related]
2. Epidemiologic Features of Kawasaki Disease in Shanghai From 2008 Through 2012.
Chen JJ, Ma XJ, Liu F, Yan WL, Huang MR, Huang M, Huang GY, Shanghai Kawasaki Disease Research Group.
Pediatr Infect Dis J; 2016 Jan 05; 35(1):7-12. PubMed ID: 26372452
[Abstract] [Full Text] [Related]
3. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin.
Kibata T, Suzuki Y, Hasegawa S, Matsushige T, Kusuda T, Hoshide M, Takahashi K, Okada S, Wakiguchi H, Moriwake T, Uchida M, Ohbuchi N, Iwai T, Hasegawa M, Ichihara K, Yashiro M, Makino N, Nakamura Y, Ohga S.
Int J Cardiol; 2016 Jul 01; 214():209-15. PubMed ID: 27070994
[Abstract] [Full Text] [Related]
4. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
Turk J Pediatr; 2019 Jul 01; 61(5):648-656. PubMed ID: 32104995
[Abstract] [Full Text] [Related]
5. A Multicenter Study of Intravenous Immunoglobulin Non-response in Kawasaki Disease.
Wei M, Huang M, Chen S, Huang G, Huang M, Qiu D, Guo Z, Jiang J, Zhou X, Yu Q, Guo Y, Fu L, Gao W, Li F.
Pediatr Cardiol; 2015 Aug 01; 36(6):1166-72. PubMed ID: 25812827
[Abstract] [Full Text] [Related]
6. Epidemiologic study of Kawasaki disease at a single hospital in Daejeon, Korea (1987 through 2000).
Lee KY, Han JW, Lee HS, Hong JH, Hahn SH, Lee JS, Whang KT.
Pediatr Infect Dis J; 2004 Jan 01; 23(1):52-5. PubMed ID: 14743047
[Abstract] [Full Text] [Related]
7. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
Li W, He X, Zhang L, Wang Z, Wang Y, Lin H, Yuan J, Xie X, Qin Y, Huang P.
Cardiovasc Ther; 2021 Jan 01; 2021():6660407. PubMed ID: 34239607
[Abstract] [Full Text] [Related]
8. Epidemiologic survey of Kawasaki disease in Jilin from 1999 through 2008.
Zhang X, Zhang Z, Liu S, Sun J.
Pediatr Cardiol; 2012 Feb 01; 33(2):272-9. PubMed ID: 21965088
[Abstract] [Full Text] [Related]
9. Risk factors for coronary artery lesions in children with Kawasaki disease.
Duan J, Jiang H, Lu M.
Arch Argent Pediatr; 2020 Oct 01; 118(5):327-331. PubMed ID: 32924395
[Abstract] [Full Text] [Related]
10. [A retrospective analysis of 602 Kawasaki disease cases with electronic data capture system].
Xie L, Zhou C, Wang R, Xiao T, Shen J, Huang M.
Zhonghua Er Ke Za Zhi; 2015 Jan 01; 53(1):34-9. PubMed ID: 25748402
[Abstract] [Full Text] [Related]
11. [Clinical analysis of 942 cases of Kawasaki disease].
Zhang W, Li Q, Zhao XD, Tang XM, Wang XG, Wang M, Wu DQ, Ou Q, Yang XQ.
Zhonghua Er Ke Za Zhi; 2006 May 01; 44(5):324-8. PubMed ID: 16780705
[Abstract] [Full Text] [Related]
12. Difference in Risk Factors for Subtypes of Acute Cardiac Lesions Resulting from Kawasaki Disease.
Yamashita M, Ae R, Yashiro M, Aoyama Y, Sano T, Makino N, Nakamura Y.
Pediatr Cardiol; 2017 Feb 01; 38(2):375-380. PubMed ID: 27878631
[Abstract] [Full Text] [Related]
13. [Risk factors for coronary artery lesions in children with Kawasaki disease].
Li Y, Wang XM, Liu YL, Shi K, Yang YF, Guo YH.
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec 01; 14(12):938-41. PubMed ID: 23234782
[Abstract] [Full Text] [Related]
14. The Risk Prediction of Coronary Artery Lesions through the Novel Hematological Z-Values in 4 Chronological Age Subgroups of Kawasaki Disease.
Cho HJ, Kim WY, Park SM, Lee JH, Shin HJ, Jang GY, Ha KS.
Medicina (Kaunas); 2020 Sep 11; 56(9):. PubMed ID: 32932823
[Abstract] [Full Text] [Related]
15. Overweight, obesity and coronary artery lesions among Kawasaki disease patients.
Shi H, Weng F, Li C, Jin Z, Hu J, Chu M, Qiu H.
Nutr Metab Cardiovasc Dis; 2021 May 06; 31(5):1604-1612. PubMed ID: 33812731
[Abstract] [Full Text] [Related]
16. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
Chang LS, Lo MH, Li SC, Yang MY, Hsieh KS, Kuo HC.
Oncotarget; 2017 Jan 10; 8(2):2044-2052. PubMed ID: 27893416
[Abstract] [Full Text] [Related]
17. Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki disease.
Qin L, Saumu MT, Wang H, Shi H, Hu X, Cheng P.
J Huazhong Univ Sci Technolog Med Sci; 2005 Jan 10; 25(3):348-50, 370. PubMed ID: 16201293
[Abstract] [Full Text] [Related]
18. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, Chen QJ, Cheng PX.
Zhonghua Er Ke Za Zhi; 2006 Dec 10; 44(12):891-5. PubMed ID: 17254453
[Abstract] [Full Text] [Related]
19. Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.
Masuda H, Ae R, Koshimizu TA, Matsumura M, Kosami K, Hayashida K, Makino N, Matsubara Y, Sasahara T, Nakamura Y.
Pediatr Cardiol; 2021 Apr 10; 42(4):969-977. PubMed ID: 33682062
[Abstract] [Full Text] [Related]
20. Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study.
Zhang X, He Y, Shao Y, Hang B, Xu Z, Chu M.
Pediatr Rheumatol Online J; 2021 Jun 26; 19(1):96. PubMed ID: 34174872
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
